
|Articles|August 1, 2004
Supplements and Featured Publications
- The Great Debate: Consensus Guidelines or Specialist Discretion for Managing Specialty Pharmaceutica
- Volume 10
- Issue 8 Suppl
Specialist Discretion for Managing Specialty Pharmaceuticals: The Ethics Argument for Discretion
Author(s)John D. Golenski, EdD
Advertisement
Articles in this issue
about 21 years ago
CME/CE Quizabout 21 years ago
The Debateabout 21 years ago
Defining the Great DebateNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Value-Based Care Interventions and Management of CKD Progression
5